Authorisations of human medicines

Within the framework of the authorisation procedure, Swissmedic assesses the quality, safety and effectiveness of the medicinal product in question on the basis of the comprehensive scientific documentation that is submitted.

If the criteria for authorisation are fulfilled, Swissmedic grants the marketing authorisation, specifies the method of sale (on prescription only/dispensing point) and approves the information for healthcare professionals and the patient information.

Informations

Show all

15.12.2025

Change to the review practice for medicinal products containing the active substance paclitaxel as paclitaxel albumin

Swissmedic is adapting its review practice for new applications for medicinal products containing the known active substance paclitaxel as paclitaxel albumin to the new EMA guideline

01.12.2025

Changes to the Guidance document Packaging for human medicinal products

A printed package leaflet can be dispensed with in future for medicinal products for use exclusively by healthcare professionals

01.11.2025

Modification of the information sheet Drug Safety Reporting Duties in Switzerland

Update of contact details and document links